Thu, October 7, 2010
Wed, October 6, 2010
Tue, October 5, 2010
Mon, October 4, 2010
Sun, October 3, 2010
Fri, October 1, 2010
Thu, September 30, 2010
Wed, September 29, 2010
Tue, September 28, 2010
Mon, September 27, 2010
Sun, September 26, 2010
Sat, September 25, 2010
Fri, September 24, 2010
Thu, September 23, 2010
Wed, September 22, 2010
Tue, September 21, 2010
Mon, September 20, 2010
Fri, September 17, 2010
Thu, September 16, 2010
Wed, September 15, 2010
Tue, September 14, 2010

Emergent BioSolutions to Participate in October 2010 Investor Conferences


  Copy link into your clipboard //health-fitness.news-articles.net/content/2010/ .. cipate-in-october-2010-investor-conferences.html
  Print publication without navigation Published in Health and Fitness on by Market Wire


ROCKVILLE, Md.--([ BUSINESS WIRE ])--Emergent BioSolutions Inc. (NYSE:EBS) announced today that the company will be participating in the following investor conferences in October 2010.

  • The 9th Annual BIO Investor Forum
    San Francisco, CA.
    October 5, 2010
    Corporate Overview Presentation
    9:00 AM Pacific
    [The presentation, which will include a discussion of the Companya™s business activities, financial outlook and current news, will be webcast live.]
  • The 17th Annual BioCentury/Thomson Reuters Newsmakers in the Biotech Industry Conference
    New York, NY.
    October 22, 2010
    Corporate Overview Presentation
    2:00 PM Eastern
    [The presentation, which will include a discussion of the Companya™s business activities, financial outlook and current news, will be webcast live.]

Both webcasts will be accessible from the Emergent website [ www.emergentbiosolutions.com ] under aInvestorsa.

About Emergent BioSolutions Inc.

Emergent BioSolutions Inc. is a biopharmaceutical company focused on the development, manufacture and commercialization of vaccines and antibody therapies that assist the bodya™s immune system to prevent or treat disease. Emergenta™s marketed product, BioThrax® (Anthrax Vaccine Adsorbed), is the only vaccine approved by the U.S. Food and Drug Administration for the prevention of anthrax infection. Emergenta™s product pipeline targets infectious diseases and includes programs focused on anthrax, tuberculosis, typhoid, flu and chlamydia. Additional information may be found at [ www.emergentbiosolutions.com ].


Publication Contributing Sources

Publication Sponsors
[ Last Sunday ] - Oceanside Rental Gear